Manuel Ramos-Casals

Manuel Ramos-Casals

UNVERIFIED PROFILE

Are you Manuel Ramos-Casals?   Register this Author

Register author
Manuel Ramos-Casals

Manuel Ramos-Casals

Publications by authors named "Manuel Ramos-Casals"

Are you Manuel Ramos-Casals?   Register this Author

100Publications

2920Reads

-Profile Views

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

J Rheumatol 2019 May 15;46(5):492-500. Epub 2019 Jan 15.

From the Rheumatology/Division of Neuro and Inflammation Sciences, Department of Clinical and Experimental Medicine, Linköping University, Linköping; Department of Medicine, Unit of Rheumatology, Karolinska Institutet and Karolinska University Hospital, Stockholm; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund; Unit for Clinical Therapy Research (ClinTRID), Karolinska University, Stockholm, Sweden; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario; Division of Rheumatology, Centre Hospitalier Universitaire (CHU) de Québec - Université Laval, Quebec City, Quebec; Division of Rheumatology, Cumming School of Medicine - University of Calgary, Calgary, Alberta; Division of Rheumatology, Department of Medicine, McGill University Health Centre, Montreal, Quebec; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; Department of Medicine and Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham; Centre for Rheumatology Research, University College, London; Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, King's College London School of Medicine, London; Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester and UK National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester University Foundation Trust, Manchester, UK; Cedars-Sinai/David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, California; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Department of Medicine, State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama; Department of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Feinstein Institute for Medical Research, Manhasset, New York; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina; Autoimmunity Institute, Allegheny Health Network, Pittsburgh, Pennsylvania; Northwestern University and Feinberg School of Medicine, Chicago, Illinois; Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia; University of California San Diego School of Medicine, La Jolla, California; Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina; Division of Rheumatology, Columbia University Medical Center, New York, New York, USA; Department of Rheumatology, Center for Rheumatology Research Fossvogur Landspitali University Hospital, Reyjkavik, Iceland; Autoimmune Disease Unit, Department of Internal Medicine, Hospital Universitario Cruces, BioCruces Health Research Institute, University of the Basque Country, Barakaldo; Josep Font Autoimmune Diseases Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Copenhagen Lupus and Vasculitis Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Rheumatology, Kantousspital, Schaffhausen, Switzerland.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.180713
Publisher Site
http://dx.doi.org/10.3899/jrheum.180713DOI Listing
May 2019

Synthetic pharmacotherapy for pulmonary sarcoidosis.

Expert Opin Pharmacother 2019 May 15:1-8. Epub 2019 May 15.

a Interstitial Lung Disease Program, Servei de Pneumologia, ICR, Hospital Clínic, Barcelona.- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , University of Barcelona , Barcelona , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2019.1615054DOI Listing
May 2019

Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis.

Expert Rev Clin Immunol 2019 Apr 26;15(4):391-405. Epub 2019 Jan 26.

a Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Department of Autoimmune Diseases , ICMiD, Hospital Clínic , Barcelona , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1744666X.2019.1568240DOI Listing
April 2019

Construction of a frailty index as a novel health measure in systemic lupus erythematosus.

J Rheumatol 2019 Apr 15. Epub 2019 Apr 15.

Department of Medicine, Division of Rheumatology, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; Division of Geriatric Medicine, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea;Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico; Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Divisions of Rheumatology and Clinical Epidemiology, Department of Medicine, McGill University, Montreal, Quebec, Canada; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA; Division of Rheumatology, CHU de Québec et Université Laval, Quebec City, Canada; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, ON, Canada; Arthritis Research UK Epidemiology Unit, Faculty of Biology Medicine and Health, Manchester Academic Health Sciences Center, The University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Center Manchester, UK; Center for Rheumatology, Department of Medicine, University College London, UK; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, UK, London, UK; Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, USA; Northwestern University and Feinberg School of Medicine, Chicago, IL, USA; Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, PA, USA; Lanarkshire Center for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland UK; Feinstein Institute for Medical Research, Manhasset, NY, USA; Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain; Emory University School of Medicine, Division of Rheumatology, Atlanta, Georgia, USA Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Unit for clinical therapy research (ClinTRID), Karolinska Institute, Stockholm, Sweden; Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden. Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Medical University of South Carolina, Charleston, South Carolina, USA; UCSD School of Medicine, La Jolla, CA, USA; Copenhagen Lupus and Vasculitis Clinic, 4242, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; University of Manitoba, Winnipeg, Manitoba, Canada; Hospital for Joint Diseases, NYU, Seligman Center for Advanced Therapeutics, New York NY; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada. Funding for this work was provided by the Nova Scotia Health Authority Research Fund. Dr. Sang-Cheol Bae's work was supported in part by NRF-2017M3A9B4050335, Republic of Korea. Dr. Caroline Gordon's work was supported by Lupus UK and the NIHR /Wellcome Trust Clinical Research Facility. The Montreal General Hospital Lupus Clinic is partially supported by the Singer Family Fund for Lupus Research. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Paul R. Fortin presently holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases at Université Laval, and part of this work was done while he was still holding a Distinguished Senior Investigator of The Arthritis Society. Dr. Bruce is a National Institute for Health Research (NIHR) Senior Investigator and is supported by Arthritis Research UK, the NIHR Manchester Biomedical Centre and the NIHR/Wellcome Trust Manchester Clinical Research Facility. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. Dr Isenberg and Dr Rahman are supported by and supported by the National Institute for Health, Research University College London Hospitals Biomedical Research Center. The Hopkins Lupus Cohort is supported by the NIH (grant AR43727 and 69572). Dr. Mary Anne Dooley's work was supported by the NIH (grant RR00046). Dr. Ramsey-Goldman's work was supported by the NIH (grants 5UL1TR001422-02, formerly 8UL1TR000150 and UL-1RR-025741, K24-AR-02318, and P60AR064464 formerly P60-AR- 48098). Dr. Ruiz-Irastorza is supported by the Department of Education, Universities and Research of the Basque Government. Dr. Soren Jacobsen is supported by the Danish Rheumatism Association (A3865) and the Novo Nordisk Foundation (A05990). Dr. John G. Hanly is supported by the Canadian Institutes of Health Research (grant MOP-88526). Address Correspondence to: Dr. John G Hanly, Division of Rheumatology, Nova Scotia Rehabilitation Centre (2nd Floor), 1341 Summer Street, Halifax, Nova Scotia, Canada, B3H 4K4.Email:

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.181338
Publisher Site
http://dx.doi.org/10.3899/jrheum.181338DOI Listing
April 2019

Sarcoidosis Involving the Gastrointestinal Tract: Diagnostic and Therapeutic Management.

Am J Gastroenterol 2019 Mar 8. Epub 2019 Mar 8.

Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14309/ajg.0000000000000171DOI Listing
March 2019

Phenotyping Sjögren's syndrome: towards a personalised management of the disease.

Clin Exp Rheumatol 2018 May-Jun;36 Suppl 112(3):198-209. Epub 2018 Jul 25.

Sjögren's Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona; and University of Barcelona, Spain.

View Article

Download full-text PDF

Source
November 2018

Cryoglobulinaemia.

Nat Rev Dis Primers 2018 Aug 2;4(1):11. Epub 2018 Aug 2.

Rheumatology Unit, Medical School, University of Modena and Reggio Emilia, Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41572-018-0009-4DOI Listing
August 2018

Cytokines as therapeutic targets in primary Sjögren syndrome.

Pharmacol Ther 2018 04 29;184:81-97. Epub 2017 Oct 29.

Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, CELLEX-IDIBAPS, Spain; Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA-Sanitas, Barcelona, Spain; Department of Autoimmune Diseases, ICMiD, Hospital Clínic Barcelona, Spain.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01637258173026
Publisher Site
http://dx.doi.org/10.1016/j.pharmthera.2017.10.019DOI Listing
April 2018

The Burden of Comorbidity and Complexity in Sarcoidosis: Impact of Associated Chronic Diseases.

Lung 2018 04 11;196(2):239-248. Epub 2017 Dec 11.

Laboratory of Systemic Autoimmune Diseases "Josep Font", CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, C/Villarroel, 170, 08036, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00408-017-0076-4
Publisher Site
http://dx.doi.org/10.1007/s00408-017-0076-4DOI Listing
April 2018

Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry).

Expert Opin Drug Saf 2017 Nov 7;16(11):1255-1271. Epub 2017 Sep 7.

b Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Department of Autoimmune Diseases , ICMiD, Hospital Clínic , Barcelona , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2017.1372421DOI Listing
November 2017

Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection.

Expert Rev Clin Pharmacol 2017 Oct 27;10(10):1085-1101. Epub 2017 Jul 27.

b Laboratory of Autoimmune Diseases Josep Font , IDIBAPS-CELLEX , Barcelona , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2017.1357466DOI Listing
October 2017

Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection.

J Hepatol 2017 06 20;66(6):1282-1299. Epub 2017 Feb 20.

Sorbonne Universités, UPMC Université Paris 06, UMR 7211, and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), F-75005 Paris, France; INSERM, UMR_S 959, F-75013 Paris, France; CNRS, FRE3632, F-75005 Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.02.010DOI Listing
June 2017

International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement.

Autoimmun Rev 2017 May 7;16(5):523-541. Epub 2017 Mar 7.

Sorbonne University, UPMC Univ Paris 06, UMR 7211, and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Paris, France; INSERM, UMR S 959, Paris, France; CNRS, FRE3632, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2017.03.004DOI Listing
May 2017

Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-Acting Antivirals.

Clin Gastroenterol Hepatol 2017 Apr 8;15(4):575-583.e1. Epub 2016 Oct 8.

Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, Institut d'Investigacions Biomédiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2016.09.158DOI Listing
April 2017

International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement.

Autoimmun Rev 2016 Dec 16;15(12):1145-1160. Epub 2016 Sep 16.

Sorbonne University, UPMC Univ Paris 06, UMR 7211, and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Paris, France; INSERM, UMR S 959, Paris, France; CNRS, FRE3632 Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2016.09.006DOI Listing
December 2016

Sarcoidosis: an update on current pharmacotherapy options and future directions.

Expert Opin Pharmacother 2016 Dec;17(18):2431-2448

a Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Department of Autoimmune Diseases , ICMiD, Hospital Clínic , Barcelona , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2016.1258061DOI Listing
December 2016

Erratum to: Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects.

Drugs 2016 Dec;76(18):1799

Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, CELLEX-IDIBAPS, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40265-016-0669-x
Publisher Site
http://dx.doi.org/10.1007/s40265-016-0669-xDOI Listing
December 2016

Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations.

Expert Rev Clin Immunol 2016 22;12(2):137-56. Epub 2015 Dec 22.

a Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, CELLEX-IDIBAPS, Department of Autoimmune Diseases, ICMiD , Hospital Clínic , Barcelona , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/1744666X.2016.1109449DOI Listing
November 2016

Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects.

Drugs 2016 Nov;76(17):1601-1623

Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, CELLEX-IDIBAPS, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-016-0659-zDOI Listing
November 2016

Epidemiologic patterns of disease expression in sarcoidosis: age, gender and ethnicity-related differences.

Clin Exp Rheumatol 2016 May-Jun;34(3):380-8. Epub 2016 Apr 6.

Laboratory of Systemic Autoimmune Diseases "Josep Font", CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Spain.

View Article

Download full-text PDF

Source
August 2016

Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjögren syndrome: analysis of 515 patients.

Rheumatology (Oxford) 2016 08 23;55(8):1443-51. Epub 2016 Apr 23.

Sjögren Syndrome Research Group, Laboratory of Autoimmune Diseases Josep Font, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kew194DOI Listing
August 2016

Sjögren syndrome.

Nat Rev Dis Primers 2016 07 7;2:16047. Epub 2016 Jul 7.

Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrdp.2016.47DOI Listing
July 2016

Therapeutic approach to IgG4-related disease: A systematic review.

Medicine (Baltimore) 2016 Jun;95(26):e4002

aAutoimmune Diseases Unit, Department of Medicine, Hospital CIMA-Sanitas bSjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX cDepartment of Autoimmune Diseases, ICMiD, Hospital Clínic dConsorci d'Atenció Primària de Salut Barcelona Esquerre (CAPS-BE) eTransverse Group for Research in Primary Care, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) fDepartment of Internal Medicine, ICMiD, Hospital Clínic, Barcelona, Spain gDepartment of Statistics, Faculty of Science and Letters, Mimar Sinan Fine Arts University, Istanbul, Turkey hDepartment of Medicine, University of Barcelona, Barcelona, Spain iHarvard Medical School and Department of Medicine (Division of Rheumatology, Allergy, and Immunology), Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000004002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937924PMC
June 2016

Complexity, comorbidity, and health care costs associated with chronic widespread pain in primary care.

Pain 2016 Apr;157(4):818-26

aConsorci d'Atenció Primària de Salut Barcelona Esquerre (CAPS-BE), Transversal Group for Research in Primary Care, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain bJosep Font Laboratory of Autoimmune Diseases, CELLEX-IDIBAPS, Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/j.pain.0000000000000440DOI Listing
April 2016

IgG4-related disease: Advances in the diagnosis and treatment.

Best Pract Res Clin Rheumatol 2016 04 6;30(2):261-278. Epub 2016 Sep 6.

Harvard Medical School and Department of Medicine, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.berh.2016.07.003DOI Listing
April 2016

Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies.

Semin Arthritis Rheum 2016 Feb 14;45(4):391-9. Epub 2015 Jul 14.

Josep Font Laboratory of Autoimmune Diseases, CELLEX-Institut d׳Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Systemic Autoimmune Diseases, Hospital Clínic, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2015.07.004DOI Listing
February 2016

How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients.

Arthritis Res Ther 2015 Sep 10;17:250. Epub 2015 Sep 10.

Josep Font Autoimmune Diseases Laboratory, CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), C/ Villarroel 170, Barcelona, 08036, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-015-0766-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570241PMC
September 2015

Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases.

Autoimmun Rev 2015 Aug 2;14(8):670-9. Epub 2015 Apr 2.

Zabludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel Hashomer, Israel Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2015.03.008DOI Listing
August 2015

Diagnostic Approach to the Complexity of IgG4-Related Disease.

Mayo Clin Proc 2015 Jul;90(7):927-39

Josep Font Laboratory of Autoimmune Diseases, CELLEX-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Spain.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00256196150027
Publisher Site
http://dx.doi.org/10.1016/j.mayocp.2015.03.020DOI Listing
July 2015

[Treatment of cryoglobulinemic vasculitis associated with hepatitis C virus infection].

Med Clin (Barc) 2015 May 29;144(9):410-7. Epub 2014 Apr 29.

Laboratorio de Enfermedades Autoinmunes Josep Font, Centro de Investigación Biomédica CELLEX-Institut d'Investigacions Biomèdiques August Pi i Sunyer (CELLEX-IDIBAPS), Servicio de Enfermedades Autoinmunes, Institut Clínic de Medicina i Dermatologia (ICMiD), Hospital Clínic, Barcelona. España. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2014.02.023DOI Listing
May 2015

The clinical spectrum of autoimmune congenital heart block.

Nat Rev Rheumatol 2015 May 24;11(5):301-12. Epub 2015 Mar 24.

Graham Hughes Lupus Research Laboratory, Division of Women's Health, King's College London, The Rayne Institute, Lambeth Wing, 4th Floor, St Thomas' Hospital, London SE1 7EH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrrheum.2015.29DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551504PMC
May 2015

Etanercept and uveitis: friends or foes?

Curr Med Res Opin 2015 Feb 5;31(2):251-2. Epub 2014 Dec 5.

Laboratory of Autoimmune Diseases Josep Font, Cellex, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases, Hospital Clínic , Barcelona , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2014.993024DOI Listing
February 2015

Etiopathogenic role of surfactant protein d in the clinical and immunological expression of primary Sjögren syndrome.

J Rheumatol 2015 Jan 1;42(1):111-8. Epub 2014 Nov 1.

From the Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS); Department of Autoimmune Diseases, Department of Internal Medicine, Instituto Clínic de Medicina y Dermatología, Immunology Department, Hospital Clínic; Primary Care Research Group, Centre d'Assistència Primària ABS Les Corts, GESCLINIC; Department of Cell Biology, Immunology and Neurosciences, School of Medicine, University of Barcelona, Barcelona; Group of Immunoreceptors, Department of Internal Medicine, Hospital Infanta Leonor, Madrid; Department of Internal Medicine, Hospital do Meixoeiro, Vigo; Department of Internal Medicine, University of Cadiz, Hospital Puerta del Mar, Cádiz, Spain.M.J. Soto-Cárdenas, MD, PhD; M. Gandía, MD, PhD, AGAUR, Laboratory of Autoimmune Diseases Josep Font, IDIBAPS, Department of Autoimmune Diseases, and the Department of Internal Medicine, University of Cadiz, Hospital Puerta del Mar; P. Brito-Zerón, MD, PhD; A. Bové, MD, PhD; S. Retamozo, MD; H. Gueitasi, MD; M. Ramos-Casals, MD, PhD, AGAUR, Laboratory of Autoimmune Diseases Josep Font, IDIBAPS, Department of Autoimmune Diseases; M.T. Arias, BSc, Immunology Department, Hospital Clínic; N. Armiger, BSc, Group of Immunoreceptors, IDIBAPS; X. Bosch, MD, PhD, Department of Internal Medicine, Instituto Clínic de Medicina y Dermatología; M. Akasbi, MD, PhD, Department of Internal Medicine, Hospital Infanta Leonor; M. Pérez-De-Lis, MD, PhD; R. Pérez-Alvarez, MD, PhD, Department of Internal Medicine, Hospital do Meixoeiro; B. Kostov, MSC; A. Siso-Almirall, MD, PhD, Primary Care Research Group, IDIBAPS, Centre d'Assistència Primària ABS Les Corts, GESCLINIC; F. Lozano, MD, PhD, Immunology Department, Hospital Clínic, Barcelona, and the Group of Immunoreceptors, IDIBAPS, and the Department of Cell Biology, Immunology and Neurosciences, School of Medicine, University of Barcelona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.140394DOI Listing
January 2015

Validation of the classification criteria for cryoglobulinaemic vasculitis.

Rheumatology (Oxford) 2014 Dec 3;53(12):2209-13. Epub 2014 Jul 3.

Rheumatology Clinic, Department of Medical and Biological Sciences, Azienda Ospedaliero Universitaria S. Maria della Misericordia, Department of Medical and Biological Sciences, Institute of Statistics, University of Udine, Udine, Italy, Laboratorio de Enfermedades Autoinmunes Josep Font, IDIBAPS, Hospital Clínic, Barcelona, Spain, Faculty of Medicine, Cairo University, Cairo, Faculty of Medicine, BeniSwafe University, BeniSwafe, Egypt, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari, Rheumatology Division, Catholic University of the Sacred Heart, Rome, Italy, Department of Pathophysiology, Medical School of Athens, Second Department of Medicine, Hippokration General Hospital, Athens, Greece, Rheumatology Unit, M. Scarlato Hospital, Scafati, Salerno, Division of Rheumatology, Arcispedale S. Maria Nuova, Reggio Emilia, Italy, Centre de Références Maladies Auto-Immunes, Service de Médecine Interne II, Hôpital Pitié-Salpêtrière, Service de Médecine Interne, Hôpital Cochin, Paris, France, Rheumatology Unit, Niguarda Ca' Granda Hospital, Milan, Internal Medicine Unit, Saronno Hospital, Azienda Ospedaliera di Busto Arsizio, Saronno, Internal Medicine, Università Politecnica delle Marche, Ancona, Rheumatology Unit, Department of Internal Medicine, University of Modena, Modena, Italy, Department of Rheumatology, University Medical Centre, Ljubljana, Slovenia, Rheumatology Unit, Department of Internal Medicine, University of Pisa, Pisa, Department of Internal Medicine, Pordenone General Hospital, Pordenone, Internal Medicine, Donizetti Hospital, Monza, Italy, Osaka Rheumatology Clinic and Department of Molecular Regulation for Intractable Diseases, Institute of Medical Science, Tokyo Medical University, Japan, Nephrology Department, A.O. Spedali Civili, Brescia, Center for Systemic Manifestations of Hepatitis Viruses (MaSVE), Department of Internal Medicine, Universit

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keu271DOI Listing
December 2014

The clinical spectrum of IgG4-related disease.

Autoimmun Rev 2014 Dec 22;13(12):1203-10. Epub 2014 Aug 22.

Harvard Medical School and Department of Medicine, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2014.08.013DOI Listing
December 2014

Advances in the understanding and treatment of systemic complications in Sjögren's syndrome.

Curr Opin Rheumatol 2014 Sep;26(5):520-7

Laboratory of Autoimmune Diseases Josep Font, CELLEX, Department of Autoimmune Diseases, ICMiD, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/BOR.0000000000000096DOI Listing
September 2014

American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort.

J Rheumatol 2014 May 1;41(5):875-80. Epub 2014 Apr 1.

From the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada; Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Department of Rheumatology, Hospital for Rheumatic Diseases and Hanyang University Medical Center, Seoul, Korea; Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Montreal General Hospital and McGill University Health Centre, Montreal, Quebec, Canada; Centre Hospitalier Universitaire de Québec et Université Laval, Quebec City, Quebec, Canada; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada; Centre for Rheumatology Research, University College, London, UK; Cedars-Sinai/David Geffen School of Medicine, University of California, Los Angeles, California, USA; Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York, USA; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA; Department of Rheumatology, University Hospital Lund, Lund, Sweden; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama, USA; Center for Rheumatology Research, Landspitali University Hospital, Reyjkavik, Iceland; Northwestern University and Feinber

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130704DOI Listing
May 2014

Adult haemophagocytic syndrome.

Lancet 2014 Apr 27;383(9927):1503-1516. Epub 2013 Nov 27.

Department of Internal Medicine, Institut Clínic de Medicina i Dermatologia, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(13)61048-XDOI Listing
April 2014

The ill endothelium: how atherosclerosis begins in lupus.

Rheumatology (Oxford) 2014 Apr 20;53(4):583-5. Epub 2014 Jan 20.

Department of Autoimmune Diseases, Hospital Clinic, C/Villarroel, 170, 08036 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/ket442DOI Listing
April 2014

Diagnosis of Liver Involvement in Primary Sjögren Syndrome.

J Clin Transl Hepatol 2013 Dec 15;1(2):94-102. Epub 2013 Dec 15.

Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://www.jcthnet.com/images/fulltext/v1i2/94_ZeronPB-JCTH-
Web Search
http://www.xandhpublishing.com/ArticleFullText.aspx?sid=2&am
Publisher Site
http://dx.doi.org/10.14218/JCTH.2013.00011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521276PMC
December 2013

Cryoglobulinemic disease.

Oncology (Williston Park) 2013 Nov;27(11):1098-1105, 1110-6

Laboratory of Autoimmune Diseases Josep Font, Department of Autoimmune Diseases, CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic, Barcelona, Spain.

View Article

Download full-text PDF

Source
November 2013

Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients.

Medicine (Baltimore) 2013 Sep;92(5):273-284

From Josep Font Laboratory of Autoimmune Diseases (SR, CDL, AB, PBZ, MEG, MRC) and Vasculitis Research Unit (MCC), Department of Autoimmune Diseases; Department of Internal Medicine (XB); Department of Immunology (JY); and Viral Hepatitis Unit (XF), Department of Hepatology; CIBERehd, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0b013e3182a5cf71DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553974PMC
September 2013

Is it time for biosimilars in autoimmune diseases?

Autoimmun Rev 2013 Aug 28;12(10):954-7. Epub 2013 Mar 28.

Louise Coote Lupus Unit, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2013.02.005DOI Listing
August 2013

The B-lymphocyte stimulator connection in Sjogren's syndrome.

Rheumatology (Oxford) 2013 Feb 4;52(2):223-5. Epub 2012 Oct 4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kes235DOI Listing
February 2013

Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions.

Expert Opin Pharmacother 2013 Feb 25;14(3):279-89. Epub 2013 Jan 25.

Servei de Malalties Autoimmunes, Hospital Clínic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14656566.2013.76
Publisher Site
http://dx.doi.org/10.1517/14656566.2013.767333DOI Listing
February 2013

Biologics-induced autoimmune diseases.

Curr Opin Rheumatol 2013 Jan;25(1):56-64

Department of Medicine, Hospital do Meixoeiro, Vigo, Institutd'InvestigacionsBiomèdiques August Pi iSunyer (IDIBAPS), Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/BOR.0b013e32835b1366DOI Listing
January 2013

[Primary Sjögren syndrome].

Praxis (Bern 1994) 2012 Nov;101(24):1565-71

Sjögren Syndrome Research Group, Department of Systemic Autoimmune Diseases, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic, Villarroel, Barcelona.

View Article

Download full-text PDF

Source
https://econtent.hogrefe.com/doi/10.1024/1661-8157/a001133
Publisher Site
http://dx.doi.org/10.1024/1661-8157/a001133DOI Listing
November 2012

Monoclonal gammopathy related to Sjögren syndrome: a key marker of disease prognosis and outcomes.

J Autoimmun 2012 Aug 31;39(1-2):43-8. Epub 2012 Jan 31.

Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2012.01.010DOI Listing
August 2012

B-cell depleting agents for ANCA vasculitides: a new therapeutic approach.

Autoimmun Rev 2012 Jul 21;11(9):646-52. Epub 2011 Nov 21.

Department of Rheumatology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2011.11.007DOI Listing
July 2012

Primary Sjogren syndrome.

BMJ 2012 Jun 14;344:e3821. Epub 2012 Jun 14.

Sjögren Syndrome Research Group, Department of Systemic Autoimmune Diseases, Institut d'Investigacions Biomèdiques August Pi i Sunyer, ICMiD, Hospital Clinic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.e3821DOI Listing
June 2012

Topical and systemic medications for the treatment of primary Sjögren's syndrome.

Nat Rev Rheumatol 2012 05 1;8(7):399-411. Epub 2012 May 1.

Sjögren's Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, Department of Autoimmune Diseases, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrrheum.2012.53DOI Listing
May 2012

The DWEYS peptide in systemic lupus erythematosus.

Trends Mol Med 2012 Apr 23;18(4):215-23. Epub 2012 Feb 23.

Department of Internal Medicine, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14714914120002
Publisher Site
http://dx.doi.org/10.1016/j.molmed.2012.01.008DOI Listing
April 2012

B-cell-depleting therapy in systemic lupus erythematosus.

Am J Med 2012 Apr;125(4):327-36

Laboratory of Autoimmune Diseases Josep Font, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2011.09.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925418PMC
April 2012

Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts.

Autoimmun Rev 2012 Mar 18;11(5):357-64. Epub 2011 Oct 18.

Laboratory of Autoimmune Diseases "Josep Font", Department of Autoimmune Diseases, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2011.10.009DOI Listing
March 2012

Connective tissue disease: Trial of SLE therapies in real-world settings.

Nat Rev Rheumatol 2012 Feb 7;8(3):128-30. Epub 2012 Feb 7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrrheum.2012.4DOI Listing
February 2012

[Fibromyalgia classification: are there different classes of patients?].

Rev Fac Cien Med Univ Nac Cordoba 2009 ;66(4):146-57

Unidad de Fibromialgia, Hospital 9 d'Octubre, Valencia.

View Article

Download full-text PDF

Source
January 2012

The cryoglobulinaemias.

Lancet 2012 Jan 23;379(9813):348-60. Epub 2011 Aug 23.

Josep Font Laboratory of Autoimmune Diseases, Institut Clínic de Medicina I Dermatologia, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(11)60242-0DOI Listing
January 2012

Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions.

Clin Dev Immunol 2012 14;2012:974648. Epub 2011 Sep 14.

Unidad de Investigación e Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/974648DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173726PMC
November 2011

Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases.

Medicine (Baltimore) 2011 Nov;90(6):359-71

Laboratory of Autoimmune Diseases Josep Font, IDIBAPS, Department of Autoimmune Diseases, ICMiD, and Liver Unit, Ciberehd, Hospital Clínic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0b013e3182380a76DOI Listing
November 2011

Basophils, IgE, and autoantibody-mediated kidney disease.

J Immunol 2011 Jun;186(11):6083-90

Department of Internal Medicine, Hospital Clinic, Institut d'Investigacions Bimoèdiques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.1002648
Publisher Site
http://dx.doi.org/10.4049/jimmunol.1002648DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466044PMC
June 2011

Pulmonary disorders induced by monoclonal antibodies in patients with rheumatologic autoimmune diseases.

Am J Med 2011 May;124(5):386-94

Department of Autoimmune Diseases, Laboratory of Autoimmune Diseases Josep Font, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2010.11.028DOI Listing
May 2011

Therapeutic targeting of B cells for rheumatic autoimmune diseases.

Pharmacol Rev 2011 Mar 18;63(1):127-56. Epub 2011 Jan 18.

Immunology Unit, Department of Cell Biology, Immunology and Neuroscience, Faculty of Medicine, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/pr.109.002006DOI Listing
March 2011

Monoclonal antibody therapy-associated neurological disorders.

Nat Rev Neurol 2011 Mar 25;7(3):165-72. Epub 2011 Jan 25.

Department of Internal Medicine, University of Barcelona, Villarroel 170, 08036-Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneurol.2011.1DOI Listing
March 2011

Therapy: Are TNF blockers safe for patients with hepatitis B virus infection?

Nat Rev Rheumatol 2010 Nov;6(11):618-20

Institut d'Investigacions Biomèdiques August Pi i Sunyer, Department of Autoimmune Diseases, Laboratory of Autoimmune Diseases Josep Font, Villarroel 170, Barcelona 08036, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrrheum.2010.156DOI Listing
November 2010

Outcomes in biopsy-proven lupus nephritis: evaluation of 190 white patients from a single center.

Medicine (Baltimore) 2010 Sep;89(5):300-7

Laboratory of Autoimmune Diseases Josep Font, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases, and Hypertension Unit, Department of Internal Medicine (AC), Institut Clínic de Medicina i Dermatologia, Hospital Clínic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0b013e3181f27e8fDOI Listing
September 2010